Novo Nordisk at FoG London 2027

Jan 27–28, 2027 London, UK ~8.3k attendees Website

Novo Nordisk takes part in 2 sessions at FoG London 2027 in London. Its program centres on AI for drug discovery. One session covers teaching AI to understand biology from experiments that perturb cells, so it can help choose which drugs to pursue.

OrganizationFoG London 2027 Attendance
Novo Nordisk
Bagsværd, Denmark
Large pharma
Danish pharmaceutical company focused on diabetes, obesity and other serious chronic diseases.
Talk
Thu Jan 28
12:30–13:00
Session (details to come)
How biology-led AI could turn many kinds of data into evidence strong enough to choose and prioritise drug targets early in research.
Talk
Thu Jan 28
15:10–15:40
Teaching AI to Understand Biology: From Cellular Perturbations to Intelligent Drug Discovery
Whether AI models, including large language models, can predict cell responses to drugs, reason about biology and run bioinformatics tasks reliably.

Explore the full FoG London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full FoG London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Novo Nordisk

Tell us what you sell and we’ll find the people at Novo Nordisk most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction